Canada'S Drug Agency

Canada'S Drug Agency company information, Employees & Contact Information

Canada’s Drug Agency is a pan-Canadian health organization. Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape. We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. --- L’Agence des médicaments du Canada est une organisation pancanadienne de la santé. Créés et financés par les gouvernements fédéral, provinciaux et territoriaux, nous sommes chargés d’améliorer la coordination, l’harmonisation et la valeur publique au sein du paysage des médicaments et des technologies de la santé au pays. Nous fournissons aux dirigeants des systèmes de santé des données probantes et des conseils indépendants pour les aider à prendre des décisions éclairées sur les médicaments, les technologies de la santé et les systèmes de santé, et nous collaborons avec des partenaires nationaux et internationaux afin de renforcer notre influence collective.

Company Details

Employees
264
Address
865 Carling Ave, Suite 600,canada
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Keywords
Ottawa.
HQ
Ottawa, Ontario
Looking for a particular Canada'S Drug Agency employee's phone or email?

Canada's Drug Agency Questions

News

Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer - Yahoo Finance

Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer Yahoo Finance

Canada's Drug Agency Welcomes Distinguished Healthcare Leader Dr. Robert Bell as New Board Chair - PR Newswire Canada

Canada's Drug Agency Welcomes Distinguished Healthcare Leader Dr. Robert Bell as New Board Chair PR Newswire Canada

Biogen Disappointed by INESSS Recommendation on SKYCLARYS™ and its Impact on Quebec Patients with Friedreich Ataxia - BioSpace

Biogen Disappointed by INESSS Recommendation on SKYCLARYS™ and its Impact on Quebec Patients with Friedreich Ataxia BioSpace

Revamped Drug Reimbursement Reviews Expected In Canada Soon - Citeline News & Insights

Revamped Drug Reimbursement Reviews Expected In Canada Soon Citeline News & Insights

Life on hold - How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams - The Macdonald-Laurier Institute

Life on hold - How Canada’s drug approval delays endanger patients: Nigel S.B. Rawson and John Adams The Macdonald-Laurier Institute

US, UK and Canada HTAs convene the Health Economics Methods Advisory - The Pharma Letter

US, UK and Canada HTAs convene the Health Economics Methods Advisory The Pharma Letter

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia - PR Newswire Canada

CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia PR Newswire Canada

Takeda's FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC) - BioSpace

Takeda's FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC) BioSpace

Biogen Disappointed by INESSS Recommendation on SKYCLARYS™ and its Impact on Quebec Patients with Friedreich Ataxia - Yahoo Finance

Biogen Disappointed by INESSS Recommendation on SKYCLARYS™ and its Impact on Quebec Patients with Friedreich Ataxia Yahoo Finance

The future of prescriptions: Pharmacogenomic testing on the verge of revolutionizing health care - Healthy Debate

The future of prescriptions: Pharmacogenomic testing on the verge of revolutionizing health care Healthy Debate

How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology - Frontiers

How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology Frontiers

Updated breast cancer costs for women by disease stage and phase of care using population-based databases - Statistique Canada

Updated breast cancer costs for women by disease stage and phase of care using population-based databases Statistique Canada

Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies” - USC Schaeffer

Response to the Draft Report of the Health Economics Methods Advisory (HEMA): “Defining Appropriate Benefits for Economic Evaluation of Health Care Technologies” USC Schaeffer

Rare disease sufferers in Canada - Orphans of “Universal” Medicare: Nigel S.B. Rawson and John Adams - The Macdonald-Laurier Institute

Rare disease sufferers in Canada - Orphans of “Universal” Medicare: Nigel S.B. Rawson and John Adams The Macdonald-Laurier Institute

Health Canada grants market authorisation to Takeda’s FRUZAQLA - Pharmaceutical Technology

Health Canada grants market authorisation to Takeda’s FRUZAQLA Pharmaceutical Technology

McQueen to Represent the United States in International Health Economics Methods Advisory - CU Anschutz newsroom

McQueen to Represent the United States in International Health Economics Methods Advisory CU Anschutz newsroom

ENHERTU® (trastuzumab deruxtecan) Receives Time-Limited Reimbursement Recommendation from Canada's Drug Agency for Gastric Cancer - PR Newswire Canada

ENHERTU® (trastuzumab deruxtecan) Receives Time-Limited Reimbursement Recommendation from Canada's Drug Agency for Gastric Cancer PR Newswire Canada

Lilly Canada remains steadfast in commitment to access options for patients amidst controversial CDA-AMC recommendation for Ebglyss™ (lebrikizumab) - PR Newswire Canada

Lilly Canada remains steadfast in commitment to access options for patients amidst controversial CDA-AMC recommendation for Ebglyss™ (lebrikizumab) PR Newswire Canada

Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC) - Yahoo Finance

Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC) Yahoo Finance

Lilly Canada secures key agreement for ulcerative colitis treatment - Benefits and Pensions Monitor

Lilly Canada secures key agreement for ulcerative colitis treatment Benefits and Pensions Monitor

Meet Canada's Outstanding Leaders in Health Technology Assessment - PR Newswire Canada

Meet Canada's Outstanding Leaders in Health Technology Assessment PR Newswire Canada

Lilly Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for OMVOH® (mirikizumab) for adults with moderately to severely active ulcerative colitis (UC) - PR Newswire Canada

Lilly Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for OMVOH® (mirikizumab) for adults with moderately to severely active ulcerative colitis (UC) PR Newswire Canada

Canada’s national pharmacare plan – boon or bane?: Nigel Rawson and John Adams - The Macdonald-Laurier Institute

Canada’s national pharmacare plan – boon or bane?: Nigel Rawson and John Adams The Macdonald-Laurier Institute

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia - PR Newswire Canada

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY® (Exagamglogene Autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia PR Newswire Canada

Column: B.C.'s mental health crisis needs more than just patchwork solutions - Vancouver Is Awesome

Column: B.C.'s mental health crisis needs more than just patchwork solutions Vancouver Is Awesome

Kitchener, Ont. woman with incurable cancer pushing province to cover rare cancer drug - CTV News

Kitchener, Ont. woman with incurable cancer pushing province to cover rare cancer drug CTV News

Cruising at Car d’Lane, CdA’s classic car show - The Spokesman-Review

Cruising at Car d’Lane, CdA’s classic car show The Spokesman-Review

Top Canada'S Drug Agency Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant